Recombinant factor VIIa treatment for life-threatening haemoptysis

Yildirim H., Ucgun I., Yalcin A. U., Gulbas Z., Sahin G., Acikalin M. F., ...Daha Fazla

RESPIROLOGY, cilt.11, sa.5, ss.652-654, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 5
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1111/j.1440-1843.2006.00906.x
  • Dergi Adı: RESPIROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.652-654
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Diffuse alveolar haemorrhage is a severe clinical disorder that may be life-threatening. The early diagnosis of diffuse alveolar haemorrhage and prompt intervention is crucial. Recombinant factor VIIa has been used extensively for the treatment of haemophilia A and B patients. More recently, recombinant factor VIIa has been used successfully for the treatment of bleeding in patients without pre-existing coagulopathy We describe the successful use of recombinant factor VIIa in a patient with diffuse alveolar haemorrhage secondary to pulmonary-renal syndrome.